HomeATAI • NASDAQ
Follow
ATAI Life Sciences NV
Previous close
$1.73
Day range
$1.68 - $1.83
Year range
$1.02 - $2.39
Market cap
297.16M USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 87.00K | 262.50% |
Operating expense | 26.92M | -29.98% |
Net income | 44.24M | 230.56% |
Net profit margin | 50.86K | 136.02% |
Earnings per share | 0.25 | 213.64% |
EBITDA | -26.76M | 30.29% |
Effective tax rate | 0.55% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 208.99M | -31.26% |
Total assets | 308.22M | -10.03% |
Total liabilities | 39.71M | -14.64% |
Total equity | 268.51M | — |
Shares outstanding | 166.01M | — |
Price to book | 1.08 | — |
Return on assets | -23.88% | — |
Return on capital | -25.70% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 44.24M | 230.56% |
Cash from operations | -18.43M | 34.28% |
Cash from investing | -46.48M | -170.38% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -64.60M | -210.60% |
Free cash flow | 1.47M | 111.91% |
About
Founded
2018
Website
Employees
133